Hemostemix Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 01 May 24 | Buy€1,089 | Thomas Smeenk | Individual | 40,000 | €0.027 | |
| 14 Dec 23 | Buy€949 | Thomas Smeenk | Individual | 20,000 | €0.047 | |
| 05 Dec 23 | Buy€621 | Thomas Smeenk | Individual | 13,000 | €0.048 | |
| 08 Nov 23 | Buy€3,249 | Thomas Smeenk | Individual | 60,000 | €0.054 | |
| 07 Nov 23 | Buy€1,189 | Thomas Smeenk | Individual | 25,000 | €0.048 | |
| 02 Nov 23 | Buy€4,440 | Thomas Smeenk | Individual | 100,000 | €0.044 | |
| 01 Nov 23 | Buy€2,393 | Thomas Smeenk | Individual | 50,000 | €0.048 |
Insider Trading Volume
Insider Buying: 2VF0 insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 150,000 | 0.172% |
| Individual Insiders | 12,489,509 | 14.3% |
| General Public | 74,482,809 | 85.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.4%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 6,096,214 | €208.1k | 0% | no data | |||
| 4,026,445 | €137.5k | 4.68% | no data | |||
| 1,800,593 | €61.5k | 2.27% | no data | |||
| 566,257 | €19.3k | 0% | no data | |||
| 150,000 | €5.1k | 0% | no data |